NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.

Biotechnology

Health Care

Life Sciences

Therapeutics

NextPoint Therapeutics, Inc.

Paul Conrad

Stephanie D.

Bijan Etemad-Gilbertson

Michael O'Meara

The Leadership Team at NextPoint Therapeutics, Inc. spearheads strategic planning and decision-making, oversees business operations, and drives the development of innovative immunotherapies. They ensure alignment between clinical development, corporate strategy, and advanced antibody technology to enhance treatment options for cancer patients.

Leadership Team

Scientific Research and Development

Business Operations and Development

Leadership Team

About

Team members

Other teams at NextPoint Therapeutics, Inc.

Scientific Research and Development

Business Operations and Development